Human psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brazil - PubMed (original) (raw)
doi: 10.1097/00005053-199602000-00004.
D J McKenna, J C Callaway, G S Brito, E S Neves, G Oberlaender, O L Saide, E Labigalini, C Tacla, C T Miranda, R J Strassman, K B Boone
Affiliations
- PMID: 8596116
- DOI: 10.1097/00005053-199602000-00004
Human psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brazil
C S Grob et al. J Nerv Ment Dis. 1996 Feb.
Abstract
A multinational, collaborative, biomedical investigation of the effects of hoasca (ayahuasca), a potent concoction of plant hallucinogens, was conducted in the Brazilian Amazon during the summer of 1993. This report describes the psychological assessment of 15 long-term members of a syncretic church that utilizes hoasca as a legal, psychoactive sacrament as well as 15 matched controls with no prior history of hoasca ingestion. Measures administered to both groups included structured psychiatric diagnostic interviews, personality testing, and neuropsychological evaluation. Phenomenological assessment of the altered state experience as well as semistructured and open-ended life story interviews were conducted with the long-term use hoasca group, but not the hoasca-naive control group. Salient findings included the remission of psychopathology following the initiation of hoasca use along with no evidence of personality or cognitive deterioration. Overall assessment revealed high functional status. Implications of this unusual phenomenon and need for further investigation are discussed.
Similar articles
- Psychological and neuropsychological assessment of regular hoasca users.
Barbosa PC, Strassman RJ, da Silveira DX, Areco K, Hoy R, Pommy J, Thoma R, Bogenschutz M. Barbosa PC, et al. Compr Psychiatry. 2016 Nov;71:95-105. doi: 10.1016/j.comppsych.2016.09.003. Epub 2016 Sep 12. Compr Psychiatry. 2016. PMID: 27653781 - Commentary. On "Human pharmacology of hoasca": a medical anthropology perspective.
Dobkin de Rios M. Dobkin de Rios M. J Nerv Ment Dis. 1996 Feb;184(2):95-98. doi: 10.1097/00005053-199602000-00005. J Nerv Ment Dis. 1996. PMID: 8596117 No abstract available. - Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of Ayahuasca: a longitudinal study.
Bouso JC, González D, Fondevila S, Cutchet M, Fernández X, Ribeiro Barbosa PC, Alcázar-Córcoles MÁ, Araújo WS, Barbanoj MJ, Fábregas JM, Riba J. Bouso JC, et al. PLoS One. 2012;7(8):e42421. doi: 10.1371/journal.pone.0042421. Epub 2012 Aug 8. PLoS One. 2012. PMID: 22905130 Free PMC article. - Health status of ayahuasca users.
Barbosa PC, Mizumoto S, Bogenschutz MP, Strassman RJ. Barbosa PC, et al. Drug Test Anal. 2012 Jul-Aug;4(7-8):601-9. doi: 10.1002/dta.1383. Epub 2012 Jul 4. Drug Test Anal. 2012. PMID: 22761152 Review. - Effects of the Natural β-Carboline Alkaloid Harmine, a Main Constituent of Ayahuasca, in Memory and in the Hippocampus: A Systematic Literature Review of Preclinical Studies.
Dos Santos RG, Hallak JE. Dos Santos RG, et al. J Psychoactive Drugs. 2017 Jan-Mar;49(1):1-10. doi: 10.1080/02791072.2016.1260189. Epub 2016 Dec 5. J Psychoactive Drugs. 2017. PMID: 27918874 Review.
Cited by
- Modulatory effects of ayahuasca on personality structure in a traditional framework.
Netzband N, Ruffell S, Linton S, Tsang WF, Wolff T. Netzband N, et al. Psychopharmacology (Berl). 2020 Oct;237(10):3161-3171. doi: 10.1007/s00213-020-05601-0. Epub 2020 Jul 23. Psychopharmacology (Berl). 2020. PMID: 32700023 Free PMC article. - Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years.
Dos Santos RG, Osório FL, Crippa JA, Riba J, Zuardi AW, Hallak JE. Dos Santos RG, et al. Ther Adv Psychopharmacol. 2016 Jun;6(3):193-213. doi: 10.1177/2045125316638008. Epub 2016 Mar 18. Ther Adv Psychopharmacol. 2016. PMID: 27354908 Free PMC article. Review. - Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines.
Belouin SJ, Averill LA, Henningfield JE, Xenakis SN, Donato I, Grob CS, Berger A, Magar V, Danforth AL, Anderson BT. Belouin SJ, et al. Neuropharmacology. 2022 Nov 15;219:109214. doi: 10.1016/j.neuropharm.2022.109214. Epub 2022 Aug 13. Neuropharmacology. 2022. PMID: 35973601 Free PMC article. Review. - Hallucinogenic potential: a review of psychoplastogens for the treatment of opioid use disorder.
Hornick MG, Stefanski A. Hornick MG, et al. Front Pharmacol. 2023 Aug 22;14:1221719. doi: 10.3389/fphar.2023.1221719. eCollection 2023. Front Pharmacol. 2023. PMID: 37675046 Free PMC article. Review. - Behavioral Changes Over Time Following Ayahuasca Exposure in Zebrafish.
Savoldi R, Polari D, Pinheiro-da-Silva J, Silva PF, Lobao-Soares B, Yonamine M, Freire FAM, Luchiari AC. Savoldi R, et al. Front Behav Neurosci. 2017 Jul 28;11:139. doi: 10.3389/fnbeh.2017.00139. eCollection 2017. Front Behav Neurosci. 2017. PMID: 28804451 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources